Cargando…
Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
OBJECTIVE: Although specific anti-phospholipid antibodies (aPLs) have been used in the diagnosis of the antiphospholipid syndrome (APS) for years, new biomarkers are required to increase its diagnostic and risk-predictive power. This study aimed to explore the value of several non-criteria aPLs in a...
Autores principales: | Hu, Chaojun, Li, Siting, Xie, Zhijuan, You, Hanxiao, Jiang, Hui, Shi, Yu, Qi, Wanting, Zhao, Jiuliang, Wang, Qian, Tian, Xinping, Li, Mengtao, Zhao, Yan, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461188/ https://www.ncbi.nlm.nih.gov/pubmed/34567005 http://dx.doi.org/10.3389/fimmu.2021.741369 |
Ejemplares similares
-
Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023) -
Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021) -
Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022) -
Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020) -
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
por: Zhou, Yangzhong, et al.
Publicado: (2023)